Inhibition of protein kinase C by ether-linked lipids is not correlated with their antineoplastic activity on WEHI-3B and R6X-B15 cells.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Biochimica et Biophysica Acta

• Publication date

  1992-02-19

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0167-4889(92)90030-FPMID 1543759
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hexadecylphosphocholine inhibits inositol phosphate formation and protein kinase C activity.

  1991cited by this paper
• Effects of hexadecylphosphocholine on protein kinase C and TPA-induced differentiation of HL60 cells

  1991cited by this paper
• Antitumoral and other biomedical activities of synthetic ether lysophospholipids.

  1990cited by this paper
• Synthesis and antineoplastic properties of ether-linked thioglycolipids.

  1990cited by this paper
• Antitumoral and Other Biomedical Activities of Synthetic Ether Lysophospholipids (Part 1 of 2)

  1990cited by this paper
• Inhibition of protein kinase C, (sodium plus potassium)-activated adenosine triphosphatase, and sodium pump by synthetic phospholipid analogues.

  1990cited by this paper
• Synthesis and biological activity of novel quaternary ammonium derivatives of alkylglycerols as potent inhibitors of protein kinase C.

  1990cited by this paper
• Protein kinase C activation by platelet-activating factor is independent of enzyme translocation.

  1990cited by this paper
• Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analogues.

  1990cited by this paper
• 1-O-hexadecyl-2-Q-methylglycerol, a novel inhibitor of protein kinase C, inhibits the respiratory burst in human neutrophils.

  1989cited by this paper
• An efficient stereocontrolled route to both enantiomers of platelet activating factor and analogs with long-chain esters at C-2: saturated and unsaturated ether glycerolipids by opening of glycidyl arenesulfonates

  1989cited by this paper
• Regulation of protein kinase C by lysophospholipids. Potential role in signal transduction.

  1988cited by this paper
• HL-60 cells become resistant towards antitumor ether-linked phospholipids following differentiation into a granulocytic form.

  1988cited by this paper
• Effects of thioether phospholipid BM 41.440 on protein kinase C and phorbol ester-induced differentiation of human leukemia HL60 and KG-1 cells.

  1988cited by this paper
• Evidence of protein kinase C involvement in phorbol diester-stimulated arachidonic acid release and prostaglandin synthesis.

  1987cited by this paper
• Ether lipids inhibit the effects of phorbol diester tumor promoters

  1987cited by this paper
• Increased membrane permeability for an antitumoral alkyl lysophospholipid in sensitive tumor cells

  1987cited by this paper
• Cytostatic activity of synthetic O-alkylglycerolipids.

  1987cited by this paper
• Metabolism of ether phospholipids and analogs in neoplastic cells

  1987cited by this paper
• A metabolite of an antineoplastic ether phospholipid may inhibit transmembrane signalling via protein kinase C

  1987cited by this paper
• Sensitivity of leukemia cell lines to cytotoxic alkyl-lysophospholipids in relation to O-alkyl cleavage enzyme activities.

  1987cited by this paper
• Purification and characterization of three types of protein kinase C from rabbit brain cytosol.

  1987cited by this paper
• Factors influencing chelator-stable, detergent-extractable, phorbol diester-induced membrane association of protein kinase C. Differences between Ca2+-induced and phorbol ester-stabilized membrane bindings of protein kinase C.

  1986cited by this paper
• Effects of the modification of transfer buffer composition and the renaturation of proteins in gels on the recognition of proteins on Western blots by monoclonal antibodies.

  1986cited by this paper
• Modulation of protein kinase C activity and [3H]phorbol 12,13-dibutyrate binding by various tumor promoters in mouse brain cytosol.

  1985cited by this paper
• Antiinvasive effect of racemic 1-O-octadecyl-2-O-methylglycero-3-phosphocholine on MO4 mouse fibrosarcoma cells in vitro.

  1985cited by this paper
• A protein kinase C inhibitory activity is present in rat brain homogenate

  1984cited by this paper
• Phospholipid-sensitive Ca2+-dependent protein phosphorylation system in various types of leukemic cells from human patients and in human leukemic cell lines HL60 and K562, and its inhibition by alkyl-lysophospholipid.

  1983cited by this paper
• Effects of alkyl-lysophospholipids on human leukemic cell lines measured by nuclear magnetic resonance.

  1983cited by this paper
• The influence of alkyl-lysophospholipids and lysophospholipid-activated macrophages on the development of metastasis of 3-Lewis lung carcinoma.

  1980cited by this paper
• Disturbance of phospholipid metabolism during the selective destruction of tumor cells induced by alkyl-lysophospholipids.

  1979cited by this paper
• Selective destruction of human leukemic cells by alkyl-lysophospholipids.

  1978cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• Lipid Signaling in Human Diseases

  2020cites this paper
• Lipids and Membrane Microdomains: The Glycerolipid and Alkylphosphocholine Class of Cancer Chemotherapeutic Drugs.

  2019cites this paper
• A reflection of the lasting contributions from Dr. Robert Bittman to sterol trafficking, sphingolipid and phospholipid research.

  2016cites this paper
• A comparative study of the effect of the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-glycero-3-phosphocholine and some homologous compounds on PKCα and PKCɛ

  2005cites this paper
• A comparative study of the effect of the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-glycero-3-phosphocholine and some homologous compounds on PKC alpha and PKC epsilon.

  2005cites this paper
• Effects of etherlipid analogs on cell membrane functions.

  2003cites this paper
• Biological activities, mechanisms of action and biomedical prospect of the antitumor ether phospholipid ET-18-OCH(3) (edelfosine), a proapoptotic agent in tumor cells.

  2002cites this paper
• Correlation between the effect of the anti-neoplastic ether lipid 1-O-octadecyl-2-O-methyl-glycero-3-phosphocholine on the membrane and the activity of protein kinase Calpha.

  2001cites this paper
• Stimulation of human hematopoietic progenitor cells by the alkylphosphocholines hexadecylphosphocholine and hexadecyl-N,N,N-trimethyl-hexanolamine.

  1999cites this paper
• Modulation of polymorphic properties of dielaidoylphosphatidylethanolamine by the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-glycero-3-phosphocholine.

  1999cites this paper
• Differential effects of free and liposome‐associated 1‐O‐octadecyl‐2‐O‐methylglycerophosphocholine on protein kinase C

  1999cites this paper
• Cytotoxic etherphospholipid analogues.

  1998cites this paper
• The inhibition of cell signaling pathways by antitumor ether lipids.

  1998cites this paper
• Quaternary ammonium analogs of ether lipids inhibit the activation of protein kinase C and the growth of human leukemia cell lines

  1998cites this paper
• Apoptosis Triggered by 1-O-Octadecyl-2-O-methyl-rac-glycero-3-phosphocholine Is Prevented by Increased Expression of CTP:Phosphocholine Cytidylyltransferase*

  1998cites this paper
• Synergistic cytotoxic effects of ether phospholipid analogues and ionizing radiation in human carcinoma cells.

  1997cites this paper
• Expression of two 50 kDa proteins is associated with sensitivity towards etherlipid analogues in the human leukaemia cell line HL 60.

  1997cites this paper
• Differential regulation of phospholipase A2 in human leukemia cells by the etherphospholipid analogue hexadecylphosphocholine.

  1997cites this paper
• 1-O-Octadecyl-2-O-methylglycerophosphocholine inhibits protein kinase C-dependent phosphorylation of endogenous proteins in MCF-7 cells.

  1997cites this paper
• Differential effect of alkyl chain-modified ether lipids on protein kinase C autophosphorylation and histone phosphorylation.

  1996cites this paper
• 1-O-octadecyl-2-O-methyl-glycerophosphocholine inhibits the transduction of growth signals via the MAPK cascade in cultured MCF-7 cells.

  1996cites this paper
• Cellular signalling as a target in cancer chemotherapy. Phospholipid analogues as inhibitors of mitogenic signal transduction.

  1996cites this paper
• Protein kinase C inhibitors and PAF stimulate phosphatidylserine synthesis in human leucocytes.

  1996cites this paper
• Inhibition of phorbol ester-stimulated arachidonic acid release by alkylglycerols.

  1995cites this paper
• Analogs of alkyllysophospholipids: chemistry, effects on the molecular level and their consequences for normal and malignant cells.

  1995cites this paper
• Phospholipid antitumor agents

  1995cites this paper
• Lysophosphatidylcholine attenuates the cytotoxic effects of the antineoplastic phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3- phosphocholine

  1995cites this paper
• Interference of new alkylphospholipid analogues with mitogenic signal transduction

  1995cites this paper
• Human endothelial cells are targets for platelet-activating factor (PAF). Activation of alpha and beta protein kinase C isozymes in endothelial cells stimulated by PAF.

  1994cites this paper
• [Ether lipids--a new structural class of antineoplastic compounds].

  1994cites this paper
• Inhibition of calcium-dependent protein kinase C by hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine do not correlate with inhibition of proliferation of HL60 and K562 cell lines.

  1994cites this paper
• Inhibiting intracellular signalling as a strategy for cancer chemoprevention.

  1994cites this paper
• Recent Advances in the Development of Anticancer Drugs that Act against Signalling Pathways

  1994cites this paper
• Ether lipids in biomembranes.

  1994cites this paper
• The alpha-anomers and Beta-anomers of 1-o-hexadecyl-2-o-methyl-3-s-thioglucosyl-sn-glycerol inhibit the proliferation of epithelial cancer cell-lines.

  1994cites this paper
• The potential of protein kinase C as a target for anticancer treatment.

  1993cites this paper
• Topical administration of hexadecylphosphocholine in patients with cutaneous lymphomas: results of a phase I/II study.

  1993cites this paper
• 1-O-hexadecyl-2-O-methyl-sn-glycero-3-phosphocholine inhibits diacylglycerol kinase in WEHI-3B cells.

  1993cites this paper
• Ability of the non‐phorbol ester‐type tumor‐promoter thapsigargin to mimic the stimulatory effects of 12‐0‐tetradecanoylphorbol‐13‐acetate on ornithine decarboxylase activity, hydroperoxide production, and macromolecule synthesis in mouse epidermis In vivo

  1993cites this paper
• Synthesis and antineoplastic properties of an ether glycerophosphonocholine, and analog of ET-18-OCH3-GPC.

  1992cites this paper
• Cytotoxic and cytostatic effects of antitumor agents induced at the plasma membrane level.

  1992cites this paper